Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
cetylpyridinium chloride + benzydamine hydrochloride + mucoadhesive polymer
- Development stage
- Unknown
- Lead developer
- KRKA
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Oromucosal, Buccal, Oral (as Lozenges/orosoluble Tablets Applied To The Mouth/throat)
01
Overview
This is a **fixed-dose combination** medication consisting of **cetylpyridinium chloride**, **benzydamine hydrochloride**, and a **mucoadhesive polymer**. Cetylpyridinium chloride is a broad-spectrum antiseptic with recognized antibacterial and antiseptic activity. Benzydamine hydrochloride is a non-steroidal anti-inflammatory drug (NSAID) of the indazole class, offering anti-inflammatory, analgesic, local anesthetic, and antipyretic actions. The mucoadhesive polymer prolongs the residence time of the drug in the oral cavity or mucosa, enabling sustained local drug delivery, improved therapeutic outcome, and protection from rapid salivary washout. The combination is primarily used for the local symptomatic relief of sore throat associated with upper respiratory tract infections. Clinical trials support its efficacy and safety in this indication, particularly as orosoluble tablets or lozenges[1][2][4][7][8].
- Brand names
- Septabene
02
Targets
COX
Beyond the preview
Go deeper on cetylpyridinium chloride + benzydamine hydrochloride + mucoadhesive polymer.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on cetylpyridinium chloride + benzydamine hydrochloride + mucoadhesive polymer.